A Pivotal, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Phase 2 Study of Me-401 Investigating Two Dosing Schedules in Patients With Follicular Lymphoma (Fl) After Failure of Two or More Prior Systemic Therapies

Hematological Oncology - United Kingdom
doi 10.1002/hon.2_2632

Related search